The Forum for Collaborative HIV Research convened the 11th HCV Drug Development Advisory Group (DrAG) Meeting in Washington DC, in conjunction with the 64th annual meeting of the American Association for the Study of Liver Diseases. The meeting was held on November 5, 2013 at the University of California, Washington Center.

Topics of discussion included:
1) Drug Toxicities Observed in Clinical Trials
2) Post-Approval Use of Sofosbuvir and/or Simeprevir in Clinical Practice  
3) The HCV DrAG Story and Future Directions

Meeting Materials and Links

Agenda
Participant List

Presentations
Veronica Miller

Session 1
Eric Hughes
Philip Yin

Session 2
Ann Kwong
Camilla Graham

Session 3
Courtney Hutchison

The Steering Committee for this project includes: 

Patrick Harrington, PhD - Center for Drug Evaluation and Research, Food and Drug Administration
Daria Hazuda, PhD - Merck Research Laboratories
Ira Jacobson, MD - Weill Medical College of Cornell University
Donald Jensen, MD, FACP - University of Chicago Medical Center
Filip Josephson, MD, PhD - European Medicines Agency
Robert Kauffman, MD, PhD* - Vertex Pharmaceuticals, Inc. 
Tara Kieffer, PhD - Vertex Pharmaceuticals, Inc. 
Veronica Miller, PhD - Forum for Collaborative HIV Research
Jeffrey Murray, MD, MPH - Center for Drug Evaluation and Research, Food and Drug Administration
Neil Parkin, PhD - Data First Consulting
Jean-Michel Pawlotsky, MD, PhD* - Universite Paris Est 
Stuart Ray, MD - Johns Hopkins University School of Medicine 
Kimberly Struble, PharmD - Center for Drug Evaluation and Research, Food and Drug Administration 
Tracy Swan - Treatment Action Group 
Heiner Wedemeyer, MD - Medizinische Hochschule Hannover
* Co-Chair